SAMDI Tech Inc, a Charles River Company

As of Monday, October 23rd our LinkedIn page will no longer be active. Earlier this year, the acquisition of SAMDI Tech Inc was completed and we are proud to be part of the Charles River Laboratories family. This acquisition will provide Charles River’s clients with seamless access to the premier, label-free HTS MS platform and create a comprehensive, industry-leading library of #drugdiscovery solutions. Please follow Charles River's LinkedIn account for updates and more.

Our in-house small molecule compound library is curated to fast track #drugdiscovery pipelines. Learn how we do all the work to make screening your targets better, faster, and as easy as ever. https://lnkd.in/dYxbPXP

Compound libraries play a critical role in initiating a successful #drugdiscovery program. Learn more in our blog about what to consider when selecting a small molecule library for your next #HTS project. https://lnkd.in/dzFDAtQ

Evaluating time, costs, and #innovation with respect to value is important when determining where and when to run hit-finding efforts, including using outsourced solutions. Learn more about maximizing #outsourcing models in #drugdiscovery beyond just time and cost in this white paper. https://lnkd.in/g8RSFAXW

Achieve your #drugdiscovery milestones with accelerated timelines and high-quality data. Learn how #SAMDI technology delivers results faster. https://lnkd.in/gimDUrez

Learn how integrating the #SAMDI #ASMS workflow can maximize the success of discovering #PROTACs and/or molecular glues for your next #drugdiscovery program. https://lnkd.in/ekzzQaGP

Today kicks off #BostonDOT23 and we’re excited to see fellow colleagues and learn what’s new in #drugdiscovery. If you are onsite and would like to connect, find us at our poster - P025 - or send us a message! 

Don’t miss Zachary A. Gurard-Levin present a scientific poster at #BostonDOT23 on #highthroughput #ASMS to discover small molecule ligands for cell surface receptors. Not attending the conference? Send us a message and we will be happy to set up a meeting to talk with you. https://lnkd.in/gFxAvP2M

Join Dr. Gurard-Levin to learn how to address the current challenge of developing biochemical and binding assays for diverse targets and analytes. Our webinar will highlight how innovations with biochip arrays and mass spectrometry are offering critical solutions to accelerate drug discovery research on virtually any target. Register to go beyond just scratching the surface of drug discovery. https://ow.ly/N0Kp50PG8rt #massspectrometry #thoughtleadership #biotech

#SAMDI ASMS accelerates hit-finding efforts for any target including #RNA with a 100x faster workflow and 5x higher validation rates. Learn how the SAMDI #ASMS platform offers better, faster solutions for #drugdiscovery.    https://lnkd.in/g8E8xZa